Lipid Metabolism Laboratory, Heart Institute, Faculdade de Medicina da Universidade de São Paulo, Brazil.
Clinics (Sao Paulo). 2011;66(9):1543-8. doi: 10.1590/s1807-59322011000900006.
To verify whether the capacity of high-density lipoprotein (HDL) to simultaneously receive nonesterified cholesterol, triglycerides, cholesteryl esters, and phospholipids changes with aging and the presence of coronary artery disease.
Cross-sectional study with biochemical analyses.
Eleven elderly patients with coronary artery disease (74 ± 5 years) were compared with the following groups of non-coronary artery disease subjects (referred to as "healthy"): 25 young (25 ± 5 years), 25 middle-aged (42 ± 6 years), and 25 elderly subjects (75 ± 8 years).
Plasma samples were incubated with a nanoemulsion labeled with radioactive lipids; the transfer of the lipids from the nanoemulsion to the HDL was measured in chemically precipitated HDL. HDL size and paraoxonase-1 activity were also determined.
The transfer of cholesteryl esters and phospholipids to high-density lipoprotein was significantly greater (p<0.001) in healthy elderly subjects than in the middle-aged and younger subjects. Non-esterified cholesterol and triglyceride transfer was not different among these three groups. The HDL size was significantly greater (p<0.001) in healthy elderly subjects than in the middle-aged and younger subjects. The paraoxonase-1 activity was similar among the groups. Compared with healthy elderly subjects, coronary artery disease elderly subjects had significantly less (p<0.05) transfer of non-esterified cholesterol, triglycerides, and cholesteryl esters to the HDL and a significantly smaller (p<0.05) HDL size.
Because lipid transfer is enhanced in healthy elderly subjects but not in those with coronary artery disease, increasing lipid transfer to HDL may be a protective mechanism against the disease.
验证高密度脂蛋白(HDL)同时接收非酯化胆固醇、甘油三酯、胆固醇酯和磷脂的能力是否随年龄增长和冠状动脉疾病的存在而变化。
生化分析的横断面研究。
11 例冠状动脉疾病老年患者(74 ± 5 岁)与以下非冠状动脉疾病受试者组(简称“健康”)进行比较:25 例年轻受试者(25 ± 5 岁)、25 例中年受试者(42 ± 6 岁)和 25 例老年受试者(75 ± 8 岁)。
将含有放射性脂质的纳米乳液与血浆样本孵育;在化学沉淀的 HDL 中测量脂质从纳米乳液转移到 HDL 的情况。还测定了 HDL 大小和对氧磷酶-1 活性。
健康老年受试者的胆固醇酯和磷脂向高密度脂蛋白的转移明显大于(p<0.001)中年和年轻受试者。这三组之间的非酯化胆固醇和甘油三酯转移没有差异。HDL 大小在健康老年受试者中明显大于(p<0.001)中年和年轻受试者。各组的对氧磷酶-1 活性相似。与健康老年受试者相比,冠状动脉疾病老年受试者向 HDL 的非酯化胆固醇、甘油三酯和胆固醇酯转移明显减少(p<0.05),HDL 大小明显减小(p<0.05)。
由于健康老年受试者的脂质转移增强,但冠状动脉疾病患者的脂质转移没有增强,因此增加脂质向 HDL 的转移可能是一种预防疾病的保护机制。